Revvity Sites Globally

Select your location.

*e-commerce not available for this region.

Australia

Austria

Belgium

Brazil *

Canada

China *

Denmark

Finland

France

Germany

Hong Kong *

India *

Ireland

Italy

Japan *

Luxembourg

Mexico *

Netherlands

Norway

Philippines *

Republic of Korea *

Singapore *

Spain

Sweden

Switzerland

Thailand *

United Kingdom

United States

cAMPZen Frozen Human Calcitonin AM2 (ADM) Cell Line, CHO-K1 Cells

The AequoScreen™ Calcitonin AM2 (ADM) Cell Line is a stable cell line co-expressing aequorin and the human recombinant Calcitonin AM2 (ADM) receptor, in CHO-K1 host cells. The addition of aequorin provides a way to measure changes in intracellular calcium levels. This specialized cell line is specifically designed and manufactured for use in drug discovery and development, particularly for high-throughput screening assays.

View product information

Feature	Specification
Application	cAMP Drug Discovery & Development
G-Alpha Natural Receptor	G_s/G_i/G_o
Validation	cAMP Downstream Phosphorylation

Request more information

View product information

Product variant

Part #:

ES-430-CF

List price

USD 915.49

Your online price:

For research use only. Not for use in diagnostic procedures. This product contains living cells.

Product information

Overview

FroZen Cells validated for cAMP testing: Calcitonin AM2 (ADM). Human Recombinant, in CHO-K1 host cell. We provide one vial of frozen cells (2.5 million cells/vial).Some of our Frozen cells may be restricted for sale in specified countries. Please inquire at your local sales office for more information. You are authorized to utilize these frozen cell preparations one time only. Any attempt to transfer, re-use, or propagate these cells is expressly unauthorized and a violation of the product terms and conditions of sale.

Specifications

Other specifications

Application	cAMP Drug Discovery & Development
Brand	cAMPZen
G-Alpha Natural Receptor	G_s/G_i/G_o
Host Cell Line	CHO-K1
Host Species	Human
One Unit Contains	1 vial(s)
Product Group	Cell Line
Receptor	Calcitonin
Second Messenger Release	cAMP
Shipping Conditions	Shipped in Dry Ice
Target Class	GPCR
Therapeutic Area	Diabetes Gastrointestinal
Unit Size	2.5 million cells
Validation	cAMP Downstream Phosphorylation